{"id":62579,"date":"2026-02-02T10:05:58","date_gmt":"2026-02-02T09:05:58","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/rws-launches-new-cns-rater-training-service-to-strengthen-data-quality-in-clinical-trials\/"},"modified":"2026-02-02T10:05:58","modified_gmt":"2026-02-02T09:05:58","slug":"rws-launches-new-cns-rater-training-service-to-strengthen-data-quality-in-clinical-trials","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/rws-launches-new-cns-rater-training-service-to-strengthen-data-quality-in-clinical-trials\/","title":{"rendered":"RWS Launches New CNS Rater Training Service to Strengthen Data Quality in Clinical Trials"},"content":{"rendered":"
\n

\nService ensures that clinicians are properly qualified, consistently trained and monitored throughout the life of a trial<\/i><\/p>\n

MAIDENHEAD, England–(BUSINESS WIRE)–RWS (RWS.L), a global AI solutions company, announces the launch of a new rater training, certification and retraining service designed specifically to improve data quality, consistency and reliability in central nervous system (CNS) clinical trials.<\/p>\n

\nThe new service helps pharmaceutical sponsors and clinical research organizations (CROs) reduce one of the biggest risks in CNS studies: variability in how clinical raters assess patients. Even small differences in rater judgment can significantly affect trial data, timelines and outcomes.<\/p>\n

\nRWS\u2019s CNS rater training service ensures that clinicians involved in patient assessments are properly qualified, consistently trained and monitored throughout the life of a trial. The service is designed for complex, global CNS programs, where long study durations, multiple assessment points and geographically dispersed teams increase the risk of inconsistent data.<\/p>\n

\n\u201cCNS trials are uniquely sensitive to rater variability,\u201d said Dan Herron, Global Vice President, Digital Health, RWS. \u201cThis service is designed to help sponsors reduce noise in the data, maintain consistency over time, and protect the scientific integrity of their CNS studies \u2013 without adding operational complexity.\u201d<\/p>\n

\nAs CNS trials become more global, decentralized and digitally enabled, challenges such as inconsistent onboarding, certification drift and uneven use of assessment tools have become harder to manage. These risks are often compounded by the use of electronic Clinical Outcome Assessment (eCOA) technologies across different regions and languages.<\/p>\n

\nRWS addresses these challenges by combining specialist CNS scientific expertise with structured training design and secure, scalable digital delivery. The service supports the full rater lifecycle and aligns with protocol requirements, regulatory expectations and modern eCOA workflows.<\/p>\n

\nService features<\/b><\/p>\n

\nThe CNS rater training service includes:<\/p>\n